Papers
2
Total Citations
185
H-Index
2
About
Dr. Jo Adaway is a leading expert in clinical mass spectrometry, with a research focus on the development and application of liquid chromatography-tandem mass spectrometry (LC-MS/MS) for therapeutic drug monitoring and endocrinology. Her seminal 2011 work, "Therapeutic drug monitoring and LC–MS/MS," has garnered 157 citations, establishing a foundational framework for the field. Dr. Adaway’s major contributions include pioneering highly sensitive methods for multiplexed analysis of steroid hormones in saliva, a critical tool for non-invasive endocrine research. Her 2017 study on 2-hydrazinopyridine derivatization demonstrated a novel approach to enhance detection of ketosteroids, addressing a key sensitivity challenge in LC-MS/MS. This work has enabled more precise and comprehensive hormone profiling, advancing both clinical diagnostics and research into conditions like stress and reproductive disorders. With a career dedicated to bridging analytical chemistry and clinical application, Dr. Adaway’s innovations have significantly improved the accuracy and utility of mass spectrometry in medicine, making her a respected figure in the field.
Research Focus
Key Achievements
Top Papers
- 1Therapeutic drug monitoring and LC–MS/MS157 citations · 2011
- 2